ADNP
Activity-dependent neuroprotector homeobox protein
Also known as: ADNP_HUMAN, ADNP1, KIAA0784
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H2P0
- Gene
- ADNP
- Ensembl
- ENSG00000101126
- Chromosome
- 20
- Canonical length
- 1102 aa
- Protein class
- Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Vasoactive intestinal peptide is a neuroprotective factor that has a stimulatory effect on the growth of some tumor cells and an inhibitory effect on others. This gene encodes a protein that is upregulated by vasoactive intestinal peptide and may be involved in its stimulatory effect on certain tumor cells. The encoded protein contains one homeobox and nine zinc finger domains, suggesting that it functions as a transcription factor. This gene is also upregulated in normal proliferative tissues. Finally, the encoded protein may increase the viability of certain cell types through modulation of p53 activity. Alternatively spliced transcript variants encoding the same protein have been described. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
1102 residues, UniProt reviewed canonical sequence.
>Q9H2P0|ADNP
1 MFQLPVNNLG SLRKARKTVK KILSDIGLEY CKEHIEDFKQ FEPNDFYLKN TTWEDVGLWD
61 PSLTKNQDYR TKPFCCSACP FSSKFFSAYK SHFRNVHSED FENRILLNCP YCTFNADKKT
121 LETHIKIFHA PNASAPSSSL STFKDKNKND GLKPKQADSV EQAVYYCKKC TYRDPLYEIV
181 RKHIYREHFQ HVAAPYIAKA GEKSLNGAVP LGSNAREESS IHCKRCLFMP KSYEALVQHV
241 IEDHERIGYQ VTAMIGHTNV VVPRSKPLML IAPKPQDKKS MGLPPRIGSL ASGNVRSLPS
301 QQMVNRLSIP KPNLNSTGVN MMSSVHLQQN NYGVKSVGQG YSVGQSMRLG LGGNAPVSIP
361 QQSQSVKQLL PSGNGRSYGL GSEQRSQAPA RYSLQSANAS SLSSGQLKSP SLSQSQASRV
421 LGQSSSKPAA AATGPPPGNT SSTQKWKICT ICNELFPENV YSVHFEKEHK AEKVPAVANY
481 IMKIHNFTSK CLYCNRYLPT DTLLNHMLIH GLSCPYCRST FNDVEKMAAH MRMVHIDEEM
541 GPKTDSTLSF DLTLQQGSHT NIHLLVTTYN LRDAPAESVA YHAQNNPPVP PKPQPKVQEK
601 ADIPVKSSPQ AAVPYKKDVG KTLCPLCFSI LKGPISDALA HHLRERHQVI QTVHPVEKKL
661 TYKCIHCLGV YTSNMTASTI TLHLVHCRGV GKTQNGQDKT NAPSRLNQSP SLAPVKRTYE
721 QMEFPLLKKR KLDDDSDSPS FFEEKPEEPV VLALDPKGHE DDSYEARKSF LTKYFNKQPY
781 PTRREIEKLA ASLWLWKSDI ASHFSNKRKK CVRDCEKYKP GVLLGFNMKE LNKVKHEMDF
841 DAEWLFENHD EKDSRVNASK TADKKLNLGK EDDSSSDSFE NLEEESNESG SPFDPVFEVE
901 PKISNDNPEE HVLKVIPEDA SESEEKLDQK EDGSKYETIH LTEEPTKLMH NASDSEVDQD
961 DVVEWKDGAS PSESGPGSQQ VSDFEDNTCE MKPGTWSDES SQSEDARSSK PAAKKKATMQ
1021 GDREQLKWKN SSYGKVEGFW SKDQSQWKNA SENDERLSNP QIEWQNSTID SEDGEQFDNM
1081 TDGVAEPMHG SLAGVKLSSQ QALocalizationUniProt · AlphaFold · HPA
Whether an antibody against ADNP can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.56
- Highest tissue expression
- 42 nTPM
Expression across tissuesHPA
Tissue
- thymus: 42 nTPM
- retina: 40 nTPM
- epididymis: 40 nTPM
- cerebellum: 39 nTPM
- testis: 38 nTPM
- ovary: 36 nTPM
Single-cell type
- sertoli cells: 312 nCPM
- neutrophils: 255 nCPM
- adrenal cortex cells: 243 nCPM
- neutrophil progenitors: 228 nCPM
- thymocytes: 222 nCPM
- renal collecting duct intercalated cells: 213 nCPM
Immune cell
- naive CD8 T-cell: 59 nTPM
- plasmacytoid DC: 58 nTPM
- non-classical monocyte: 53 nTPM
- memory CD4 T-cell: 45 nTPM
- naive CD4 T-cell: 44 nTPM
- MAIT T-cell: 43 nTPM
Brain region
- cerebellum: 55 nTPM
- white matter: 53 nTPM
- hypothalamus: 50 nTPM
- basal ganglia: 45 nTPM
- cerebral cortex: 45 nTPM
- midbrain: 44 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ADNP.
Disease | AllUniProt
Conditions ADNP is implicated in, by any mechanism.
- Helsmoortel-van der Aa syndrome (HVDAS) MIM:615873
Disease | GeneticClinVar
167 pathogenic / likely-pathogenic of 911 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder
- Inborn genetic diseases
- Intellectual disability
- ADNP-related disorder
- See cases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.12
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.07
- DepMap mean gene effect
- -0.14
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 12% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cGMP-mediated signaling
- estrous cycle
- intracellular nitric oxide homeostasis
- negative regulation of gene expression
- negative regulation of neuron apoptotic process
- negative regulation of synaptic transmission
- neuron apoptotic process
- neuron differentiation
- positive regulation of axon extension
- positive regulation of canonical Wnt signaling pathway
- positive regulation of neuron projection development
- positive regulation of synapse assembly
- regulation of gene expression
- regulation of transcription by RNA polymerase II
- response to carbohydrate
- short-term memory
Molecular functions
- beta-catenin binding
- beta-tubulin binding
- chromatin binding
- copper ion binding
- DNA-binding transcription factor activity, RNA polymerase II-specific
- peptide binding
- RNA polymerase II transcription regulatory region sequence-specific DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ADNP in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ADNP as an antibody target. Whether an autoantibody or antibody against ADNP could matter depends on whether native ADNP is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ADNP is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ADNP as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...